Vanguard Group Inc X4 Pharmaceuticals, Inc Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,440,730 shares of XFOR stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,440,730

Previous 8,290,050 1.82%

Holding current value

$2.87 Million

Previous $4.81 Million 17.62%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.54 - $0.86 $81,367 - $129,584	150,680 Added 1.82%	8,440,730 $5.66 Million
Q2 2024 Aug 13, 2024	BUY	$0.58 - $1.47 $268,147 - $679,614	462,323 Added 5.91%	8,290,050 $4.81 Million
Q1 2024 May 10, 2024	SELL	$0.72 - $1.46 $130,419 - $264,461	-181,138 Reduced 2.26%	7,827,727 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $112,330 - $182,306	184,148 Added 2.35%	8,008,865 $6.73 Million
Q3 2023 Nov 14, 2023	BUY	$1.03 - $2.02 $38,704 - $75,905	37,577 Added 0.48%	7,824,717 $8.53 Million
Q2 2023 Aug 14, 2023	BUY	$0.82 - $2.49 $2.82 Million - $8.57 Million	3,442,829 Added 79.25%	7,787,140 $15.1 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $1.22 $611,137 - $931,984	763,922 Added 21.34%	4,344,311 $3.78 Million
Q4 2022 Feb 10, 2023	BUY	$0.69 - $2.21 $256,877 - $822,752	372,286 Added 11.6%	3,580,389 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $2.22 Million - $4.26 Million	2,492,928 Added 348.58%	3,208,103 $5.49 Million
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $54,551 - $118,400	61,990 Added 9.49%	715,175 $690,000
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $414,481 - $722,541	-280,055 Reduced 30.01%	653,185 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $2,112 - $6,227	-1,112 Reduced 0.12%	933,240 $2.14 Million
Q3 2021 Nov 12, 2021	BUY	$4.53 - $6.45 $166,300 - $236,785	36,711 Added 4.09%	934,352 $4.94 Million
Q2 2021 Aug 13, 2021	BUY	$6.49 - $9.56 $5.83 Million - $8.58 Million	897,641 New	897,641 $5.83 Million

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc X4 Pharmaceuticals, Inc Transaction History